Latest filing published 07 Jan 2013 for Anthera Pharmaceuticals Inc, €1,261.
Insider track record
No signal scores available.
Georgina Kilfoil: trading record in brief
Georgina Kilfoil discloses dealings in Anthera Pharmaceuticals Inc to SEC (Form 4). In total, 5 filings cover trades dated from 30 June 2010 to 3 January 2013.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 7 January 2013 came the latest disclosure, a share grant for €1,261 in Anthera Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Georgina Kilfoil
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,410 shares@ US$0.69Common StockSEC:0001214659-13-000083:0
- 2,068 shares@ US$0.69Common StockSEC:0001104659-12-047527:0
- 5,243 sharesCommon StockSEC:0001104659-12-007167:0
- 5,625 shares@ US$8.17Common StockSEC:0001209191-11-037918:0
- 22,500 sharesCommon StockSEC:0001209191-10-037154:0
5 of 5 declarations